WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

AN OVERVIEW OF MUCORMYCOSIS

Prof. Ashwini Shrikrushna Taware*

Abstract

Mucormycosis is an emerging fungal infection worldwide, with devastating disease symptoms and diverse clinical manifestations. The most important underlying risk factors are immunosuppression, poorly controlled diabetes, iron overload and major trauma. The clinical presentation of mucormycosis is initially indistinguishable from other common infections, and if not diagnosed early and aggressively treated, it is almost always fatal. Early diagnosis is critical to patient survival but, unlike Aspergillus diseases, where a number of CEmarked or FDA-approved biomarker tests are now available for clinical diagnosis, similar tests for fusariosis, scedosporiosis and mucormycosis remain experimental, with detection reliant on insensitive and slow culture of pathogens from invasive Broncho alveolar lavage fluid, tissue biopsy, or from blood. This article shortly explains the types of mucormycosis, clinical manifestations and risk factors, etiopathogenesis of mucormycosis, transmission of mucromycosis, clinical manifestations or side effects of mucormycosis, diagnosis, treatment, and recent advances in the management of mucormycosis.

Keywords: Mucormycosis, Risk factors, Etiopathogenesis, Diagnosis, Treatment, Recent advances.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More